Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Short term Debt (2018 - 2020)

Historic Short term Debt for Neurocrine Biosciences (NBIX) over the last 3 years, with Q3 2020 value amounting to $425.0 million.

  • Neurocrine Biosciences' Short term Debt changed N/A to $425.0 million in Q3 2020 from the same period last year, while for Sep 2020 it was $425.0 million, marking a year-over-year change of. This contributed to the annual value of $408.8 million for FY2019, which is N/A changed from last year.
  • Neurocrine Biosciences' Short term Debt amounted to $425.0 million in Q3 2020.
  • Over the past 5 years, Neurocrine Biosciences' Short term Debt peaked at $425.0 million during Q3 2020, and registered a low of $383.6 million during Q3 2018.
  • Its 3-year average for Short term Debt is $409.2 million, with a median of $414.2 million in 2019.